Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Omipalisib | 3.1623 | uM | 3 | 156.25 | 80.34 | 61.00 | 89.50 | 0.6816 | -0.8295 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 100.00 | 89.50 | 1.1173 | 3.0780 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 106.00 | 89.50 | 1.1844 | 4.9289 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 316.00 | 458.00 | 0.6900 | 0.2801 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 459.00 | 458.00 | 1.0022 | 1.0053 | |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 312.50 | 257.33 | 428.00 | 458.00 | 0.9345 | 0.8436 |
| SK-BR-3 | Omipalisib | 1 | uM | 3 | 312.50 | 257.33 | 254.00 | 458.00 | 0.5546 | -0.0156 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 312.50 | 257.33 | 413.00 | 458.00 | 0.9018 | 0.7661 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 312.50 | 257.33 | 251.00 | 458.00 | 0.5480 | -0.0295 |
| SK-BR-3 | Palbociclib | 10 | uM | 3 | 312.50 | 257.33 | 361.00 | 458.00 | 0.7882 | 0.5023 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 462.00 | 458.00 | 1.0087 | 1.0210 |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 312.50 | 257.33 | 291.00 | 458.00 | 0.6354 | 0.1593 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 312.50 | 257.33 | 428.00 | 458.00 | 0.9345 | 0.8436 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 312.50 | 257.33 | 419.00 | 458.00 | 0.9149 | 0.7970 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 312.50 | 257.33 | 521.00 | 458.00 | 1.1376 | 1.3352 |
| SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 312.50 | 257.33 | 419.00 | 458.00 | 0.9149 | 0.7970 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 3 | 312.50 | 257.33 | 445.00 | 458.00 | 0.9716 | 0.9319 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 312.50 | 257.33 | 158.00 | 458.00 | 0.3450 | -0.4437 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 593.00 | 458.00 | 1.2948 | 1.7285 | |
| SK-BR-3 | Palbociclib | 1 | uM | 3 | 312.50 | 257.33 | 343.00 | 458.00 | 0.7489 | 0.4127 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 312.50 | 257.33 | 412.00 | 458.00 | 0.8996 | 0.7610 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 296.00 | 458.00 | 0.6463 | 0.1833 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 312.50 | 257.33 | 403.00 | 458.00 | 0.8799 | 0.7149 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 312.50 | 257.33 | 356.00 | 458.00 | 0.7773 | 0.4773 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 312.50 | 257.33 | 198.00 | 458.00 | 0.4323 | -0.2703 |